<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04040413</url>
  </required_header>
  <id_info>
    <org_study_id>SMC-14-1828</org_study_id>
    <nct_id>NCT04040413</nct_id>
  </id_info>
  <brief_title>Database Maintenance for Bariatric Procedures</brief_title>
  <official_title>Institutional Bariatric Database Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bariatric surgery registry for quality control and investigational purposes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>Surgery type</measure>
    <time_frame>10 years</time_frame>
    <description>Sleeve gastrectomy or Roux-Y gastric bypass (RYGBP) or Single anastomosis gastric bypass (SAGB) or biliopancreatic diversion (BPD/DS) or single anastomosis duodeno-ilial bypass (SADI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent total weight loss (%TWL)</measure>
    <time_frame>1 year from surgery</time_frame>
    <description>[(Weight at time of surgery - Weight at time point)/Weight at time of surgery]X100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent total weight loss (%TWL)</measure>
    <time_frame>5 years from surgery</time_frame>
    <description>[(Weight at time of surgery - Weight at time point)/Weight at time of surgery]X100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent total weight loss (%TWL)</measure>
    <time_frame>10 years from surgery</time_frame>
    <description>[(Weight at time of surgery - Weight at time point)/Weight at time of surgery]X100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent BMI loss (%BMIL)</measure>
    <time_frame>1 year from surgery</time_frame>
    <description>[BMI at time of surgery - BMI at time point)/BMI at time of surgery] X 100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent BMI loss (%BMIL)</measure>
    <time_frame>5 years from surgery</time_frame>
    <description>[BMI at time of surgery - BMI at time point)/BMI at time of surgery] X 100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent BMI loss (%BMIL)</measure>
    <time_frame>10 years from surgery</time_frame>
    <description>[BMI at time of surgery - BMI at time point)/BMI at time of surgery] X 100</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Co-morbidity resolution</measure>
    <time_frame>1 year from surgery</time_frame>
    <description>Cessation of medication/s used to treat weight-related co-morbidities (i.e. diabetes mellitus type 2, hypertension, dyslipidemia, degenerative joint disease etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Co-morbidity resolution</measure>
    <time_frame>5 years from surgery</time_frame>
    <description>Cessation of medication/s used to treat weight-related co-morbidities (i.e. diabetes mellitus type 2, hypertension, dyslipidemia, degenerative joint disease etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Co-morbidity resolution</measure>
    <time_frame>10 years from surgery</time_frame>
    <description>Cessation of medication/s used to treat weight-related co-morbidities (i.e. diabetes mellitus type 2, hypertension, dyslipidemia, degenerative joint disease etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 day morbidity/mortality</measure>
    <time_frame>up to 30 days from intervention</time_frame>
    <description>30 day morbidity/mortality according to Clavien Dindo criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>long-term morbidity/mortality</measure>
    <time_frame>31 days to 10 years from surgery</time_frame>
    <description>morbidity/mortality according to Clavien Dindo criteria after 30 days</description>
  </secondary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Obesity, Morbid</condition>
  <condition>Bariatric Surgery Candidate</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>bariatric surgery</intervention_name>
    <description>All bariatric procedures</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All morbidly obese individuals seeking bariatric surgery and approved by multidisciplinary
        bariatric committee.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  morbid obesity

        Exclusion Criteria:

          -  unfit for surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>65261</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Goitein, MD</last_name>
      <phone>97235302714</phone>
      <email>david.goitein@sheba.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Gal Levi</last_name>
      <phone>97235307595</phone>
      <email>gal.levi@sheba.health.gov.il</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 26, 2019</study_first_submitted>
  <study_first_submitted_qc>July 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2019</study_first_posted>
  <last_update_submitted>July 29, 2019</last_update_submitted>
  <last_update_submitted_qc>July 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>David Goitein MD</investigator_full_name>
    <investigator_title>Head, Bariatric and Metabolic Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

